531015 — Venmax Drugs and Pharmaceuticals Balance Sheet
0.000.00%
- IN₹173.98m
- IN₹167.86m
- IN₹80.25m
Annual balance sheet for Venmax Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.003 | 0.003 | 0.025 | 24.8 | 12.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.364 | 0.364 | 0 | 25.6 | 87.8 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.33 | 1.38 | 0.156 | 51.3 | 162 |
| Net Property, Plant And Equipment | 0.556 | 0.5 | 0.45 | 0.405 | 0.365 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.14 | 2.11 | 0.814 | 51.7 | 162 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.5 | 9.21 | 7.27 | 7.57 | 20.3 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11.5 | 9.26 | 7.32 | 7.58 | 20.8 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -9.4 | -7.14 | -6.5 | 44.1 | 141 |
| Total Liabilities & Shareholders' Equity | 2.14 | 2.11 | 0.814 | 51.7 | 162 |
| Total Common Shares Outstanding |